{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T22:44:22Z","timestamp":1792277062577,"version":"4.4.0"},"reference-count":39,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2012,3,23]],"date-time":"2012-03-23T00:00:00Z","timestamp":1332460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Respiratory J"],"published-print":{"date-parts":[[2013,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Introduction:\u2002<\/jats:bold> Inhaled corticosteroids (ICS) and oral leukotriene receptor antagonists (LTRA) are effective drugs used in the management of asthma as controller monotherapy in adolescents and adults, although there are debates as to which one is better.<\/jats:p><jats:p><jats:bold>Objectives:\u2002<\/jats:bold> To thoroughly compare the efficacy and tolerability of ICS vs LTRA in adolescents and adults with mild to moderate asthma.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> Relative database were searched for the review. Randomized controlled trials of more than or equal to 4 weeks' treatment duration comparing ICS with LTRA were reviewed.<\/jats:p><jats:p><jats:bold>Results and Conclusion:\u2002<\/jats:bold> Twenty\u2010four trials with 6197 randomized adolescents and adults with mild to moderate asthma met the inclusion criteria with a minimum duration of 4 weeks' treatment. Significant differences favouring ICS were found in all indices of pulmonary function. Other significant benefits of ICS were shown in symptoms, nocturnal awakenings, rescue\u2010medication use, symptom\u2010free days and quality of life. As to each special symptom of adverse effects, ICS was similar to LTRA in the incidence of headache, nausea and throat discomfort, but significantly higher in the incidence of hoarseness and oral pharyngeal candidiasis. Concerning withdrawal because of adverse events potentially related to treatment, ICS was similar to LTRA but significantly superior to LTRA in decreasing the asthma exacerbations or attacks during the treatment period. These results show that ICS may be the better drug in terms of efficacy and tolerability, except hoarseness and oral pharyngeal candidiasis, and should thus have priority over LTRA in asthma monotherapy in adolescents and adults.<\/jats:p><jats:p>Please cite this paper as: Yang D, Luo H, Wang J, Bunjhoo H, Xu Y and Xiong W. Comparison of inhaled corticosteroids and leukotriene receptor antagonists in adolescents and adults with mild to moderate asthma: a meta\u2010analysis. <jats:italic>Clin Respir J<\/jats:italic> 2013; 7: 74\u201390.<\/jats:p>","DOI":"10.1111\/j.1752-699x.2012.00287.x","type":"journal-article","created":{"date-parts":[[2012,2,24]],"date-time":"2012-02-24T11:49:09Z","timestamp":1330084149000},"page":"74-90","source":"Crossref","is-referenced-by-count":6,"title":["Comparison of inhaled corticosteroids and leukotriene receptor antagonists in adolescents and adults with mild to moderate asthma: a meta\u2010analysis"],"prefix":"10.1111","volume":"7","author":[{"given":"Danlei","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hansvin","family":"Bunjhoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weining","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,3,23]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69289-1"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.3.367"},{"issue":"2","key":"e_1_2_5_4_2","article-title":"Anti\u2010leukotriene agents compared to inhaled corticosteroids in the management of recurrent and\/or chronic asthma in adults and children","author":"Ng D","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002314"},{"issue":"3","key":"e_1_2_5_6_2","article-title":"Anti\u2010leukotriene agents compared to inhaled corticosteroids in the management of recurrent and\/or chronic asthma","author":"Ducharme FM","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.06-0180"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-010-9491-z"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7109.629"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.15.2008"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1157\/13072922"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2004.00631.x"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.03.00028803"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2000.106043"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(02)01099-9"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.114657"},{"issue":"7","key":"e_1_2_5_18_2","first-page":"595","article-title":"Fluticasone propionate compared with zafirlukast in controlling persistent asthma: a randomized double\u2010blind, placebo\u2010controlled trial","volume":"50","author":"Busse W","year":"2001","journal-title":"J Fam Pract"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2002.120559"},{"issue":"2","key":"e_1_2_5_20_2","first-page":"87","article-title":"Comparative evaluation of the leukotriene receptor antagonist pranlukast versus the steroid inhalant fluticasone in the therapy of aged patients with mild bronchial asthma","volume":"57","author":"Horiguchi T","year":"2007","journal-title":"Arzneimittelforschung"},{"key":"e_1_2_5_21_2","first-page":"A641","article-title":"Randomized, open\u2010label pilot study comparing the effects of montelukast sodium tablets, fluticasone aerosol inhaler, and budesonide dry powder inhaler on asthma control in mild asthmatics","volume":"159","author":"Hughes GL","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2002.129413"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2004.021634"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.02.00304202"},{"issue":"25","key":"e_1_2_5_25_2","first-page":"419","article-title":"Comparative efficacy of zafirlukast & low dose steroids in asthmatics on prn beta2\u2010agonists","volume":"10","author":"Laitinen LA","year":"1997","journal-title":"Eur Respir J"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-130-6-199903160-00005"},{"issue":"5","key":"e_1_2_5_27_2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0025-6196(11)62212-X","article-title":"Efficacy and safety of low\u2010dose fluticasone propionate compared with montelukast for maintenance treatment of persistent asthma","volume":"77","author":"Meltzer EO","year":"2002","journal-title":"Mayo Clin Proc"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(01)00800-2"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2004.02041.x"},{"issue":"5","key":"e_1_2_5_30_2","first-page":"317\u201321","article-title":"Effectiveness and safety of montelukast versus budesonide at difference doses on bronchial reactivity in subjects with mild persistent asthma","volume":"153","author":"Riccioni G","year":"2002","journal-title":"Clin Ter"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1094-5539(03)00002-6"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.155.4.9105060"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2222.2001.01085.x"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2003.07.007"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2005.03.003"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)62372-1"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-0546(09)70248-4"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003137.pub4"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2003.1502"},{"key":"e_1_2_5_40_2","unstructured":"Global Initiative for Asthma (GINA).Global strategy for asthma management and prevention. Global Initiative for Asthma (GINA) National Heart Lung and Blood Institute Bethesda MD 2006. Available at:http:\/\/www.ginasthma.org(accessed December 2011)."}],"container-title":["The Clinical Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1752-699X.2012.00287.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1752-699X.2012.00287.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T19:08:14Z","timestamp":1697396894000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1752-699X.2012.00287.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,23]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["10.1111\/j.1752-699X.2012.00287.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1752-699x.2012.00287.x","archive":["Portico"],"relation":{},"ISSN":["1752-6981","1752-699X"],"issn-type":[{"value":"1752-6981","type":"print"},{"value":"1752-699X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,23]]}}}